Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03359239
Recruitment Status : Recruiting
First Posted : December 2, 2017
Last Update Posted : June 18, 2019
Genentech, Inc.
Information provided by (Responsible Party):
Matthew Galsky, Icahn School of Medicine at Mount Sinai

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : April 2020